Ondansetron
Product Images NDC 67296-1137

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67296-1137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg (30 Tablets Bottle))

This is a bottle of Rising Noc57237-077-30 orally disintegrating tablets containing Ondansetron USP 4 mg. The bottle has 30 tablets and should be stored between 20" to 25°C (68" to 77°F), with excursions permitted to 15° to 30°C (69° to 86°F). The drug comes in a tight, light-resistant container and is distributed by Rising Health, LLC. The dosage instructions and administration can be found in the package insert, and the tablets meet USP Disintegration Test 2. Finally, the containers are made in India and printed with a P1420597 code. Note: This product contains phenylalanine.*

FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))

This appears to be a label for a medication called Ondansetron. The medication is in the form of orally disintegrating tablets and is packaged in a bottle of 30 tablets divided into 3 blister cards. The manufacturer is listed as Rising with the NDC number of 57237-077-10. There are also some numbers and text which are not readable, but the majority of the label information is provided.*

FDA Label Image

Package Label-principal Display Panel (8 mg (30 Tablets Bottle))

Rising® Noc57237-078-30 is a medication available in the form of orally disintegrating tablets containing ondansetron USP Ema for the prevention of nausea and vomiting. It is important to note that this medication contains phenylalanine and should only be used as per the doctor's prescription. This medication should be stored at 20°C-25°C (68°F-77°F) with permissible excursions to 15°C-30°C (59°F-86°F). The tablets should be kept in their bottle until use. It meets the USP Disintegration Test 2 and should be dispensed in a tight, light-resistant container as defined by the USP. Other details are not available.*

FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))

FDA Label Image

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.